<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33564045</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Feb</Month><Day>09</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Using blood data for the differential diagnosis and prognosis of motor neuron diseases: a new dataset for machine learning applications.</ArticleTitle><Pagination><StartPage>3371</StartPage><MedlinePgn>3371</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">3371</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-82940-8</ELocationID><Abstract><AbstractText>Early differential diagnosis of several motor neuron diseases (MNDs) is extremely challenging due to the high number of overlapped symptoms. The routine clinical practice is based on clinical history and examination, usually accompanied by electrophysiological tests. However, although previous studies have demonstrated the involvement of altered metabolic pathways, biomarker-based monitoring tools are still far from being applied. In this study, we aim at characterizing and discriminating patients with involvement of both upper and lower motor neurons (i.e., amyotrophic lateral sclerosis (ALS) patients) from those with selective involvement of the lower motor neuron (LMND), by using blood data exclusively. To this end, in the last ten years, we built a database including 692 blood data and related clinical observations from 55 ALS and LMND patients. Each blood sample was described by 108 analytes. Starting from this outstanding number of features, we performed a characterization of the two groups of patients through statistical and classification analyses of blood data. Specifically, we implemented a support vector machine with recursive feature elimination (SVM-RFE) to automatically diagnose each patient into the ALS or LMND groups and to recognize whether they had a fast or slow disease progression. The classification strategy through the RFE algorithm also allowed us to reveal the most informative subset of blood analytes including novel potential biomarkers of MNDs. Our results show that we successfully devised subject-independent classifiers for the differential diagnosis and prognosis of ALS and LMND with remarkable average accuracy (up to 94%), using blood data exclusively.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Greco</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Information Engineering, Faculty of Engineering, University of Pisa, Pisa, Italy. alberto.greco@unipi.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiesa</LastName><ForeName>Maria Rosa</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Institute of Clinical Physiology Research, CNR-Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Da Prato</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute of Clinical Physiology Research, CNR-Pisa, Pisa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NeuroCare onlus, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romanelli</LastName><ForeName>Anna Maria</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Institute of Clinical Physiology Research, CNR-Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dolciotti</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Clinical Physiology Research, CNR-Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavallini</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Translational Medicine Dpt, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masciandaro</LastName><ForeName>Silvia Maria</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Institute of Clinical Physiology Research, CNR-Pisa, Pisa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NeuroCare onlus, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scilingo</LastName><ForeName>Enzo Pasquale</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>Department of Information Engineering, Faculty of Engineering, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Carratore</LastName><ForeName>Renata</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Clinical Physiology Research, CNR-Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bongioanni</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Severe Acquired Brain Injuries Dpt Section, Azienda Ospedaliero-Universitaria, Pisa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NeuroCare onlus, Pisa, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003936" MajorTopicYN="Y">Diagnosis, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="Y">Motor Neuron Disease</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>10</Day><Hour>5</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33564045</ArticleId><ArticleId IdType="pmc">PMC7873306</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-82940-8</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-82940-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>McDermott CJ, Shaw PJ. Diagnosis and management of motor neurone disease. BMJ. 2008;336:658&#x2013;662. doi: 10.1136/bmj.39493.511759.BE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39493.511759.BE</ArticleId><ArticleId IdType="pmc">PMC2270983</ArticleId><ArticleId IdType="pubmed">18356234</ArticleId></ArticleIdList></Reference><Reference><Citation>Douglass C, Kandler RH, Shaw PJ, Mcdermott CJ. An evaluation of neurophysiological criteria used in the diagnosis of motor neuron disease. J. Neurol. Neurosurg. Psychiatry. 2010;81:646&#x2013;649. doi: 10.1136/jnnp.2009.197434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.197434</ArticleId><ArticleId IdType="pubmed">20522872</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A, et al. A revision of the el escorial criteria-2015. Amyotroph Lateral Scler Frontotemp. Degener. 2015;16:291&#x2013;292. doi: 10.3109/21678421.2015.1049183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1049183</ArticleId><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Q-Q, Wu Z-Y. Amyotrophic lateral sclerosis: Precise diagnosis and individualized treatment. Chin. Med. J. 2017;130:2269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5634073</ArticleId><ArticleId IdType="pubmed">28937029</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang M, et al. Model-based and model-free techniques for amyotrophic lateral sclerosis diagnostic prediction and patient clustering. Neuroinformatics. 2019;17:407&#x2013;421. doi: 10.1007/s12021-018-9406-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12021-018-9406-9</ArticleId><ArticleId IdType="pmc">PMC6527505</ArticleId><ArticleId IdType="pubmed">30460455</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller H.-P, et al. Fast progressive lower motor neuron disease is an ALS variant: A two-centre tract of interest-based MRI data analysis. NeuroImage Clin. 2018;17:145&#x2013;152. doi: 10.1016/j.nicl.2017.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2017.10.008</ArticleId><ArticleId IdType="pmc">PMC5651542</ArticleId><ArticleId IdType="pubmed">29071208</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinelli EG, et al. Brain MRI shows white matter sparing in Kennedy&#x2019;s disease and slow-progressing lower motor neuron disease. Hum. Brain Mapp. 2019;40:3102&#x2013;3112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6865482</ArticleId><ArticleId IdType="pubmed">30924230</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Zhou M, Liu Q. An embedded feature selection method for imbalanced data classification. IEEE/CAA J. Autom. Sin. 2019;6:703&#x2013;715. doi: 10.1109/JAS.2019.1911447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/JAS.2019.1911447</ArticleId></ArticleIdList></Reference><Reference><Citation>Kueffner R, et al. Stratification of amyotrophic lateral sclerosis patients: A crowdsourcing approach. Sci. Rep. 2019;9:1&#x2013;14. doi: 10.1038/s41598-018-36873-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-36873-4</ArticleId><ArticleId IdType="pmc">PMC6345935</ArticleId><ArticleId IdType="pubmed">30679616</ArticleId></ArticleIdList></Reference><Reference><Citation>Motor Neuron Diseases Fact Sheet. https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Motor-Neuron-Diseases-Fact-Sheet (2019). Accessed: 2019-09-01.</Citation></Reference><Reference><Citation>Lacomis, D. &amp; Gooch, C. Upper motor neuron assessment and early diagnosis in ALS: Getting it right the first time (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30635480</ArticleId></ArticleIdList></Reference><Reference><Citation>Pampalakis G, et al. New molecular diagnostic trends and biomarkers for amyotrophic lateral sclerosis. Hum. Mutat. 2019;40:361&#x2013;373. doi: 10.1002/humu.23697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.23697</ArticleId><ArticleId IdType="pubmed">30556231</ArticleId></ArticleIdList></Reference><Reference><Citation>El Brooks BR. escorial world federation of neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J. Neurol. Sci. 1994;124:96&#x2013;107. doi: 10.1016/0022-510X(94)90191-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(94)90191-0</ArticleId><ArticleId IdType="pubmed">7807156</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, El Munsat TL. El escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Scler. Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>De Carvalho M, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin. Neurophysiol. 2008;119:497&#x2013;503. doi: 10.1016/j.clinph.2007.09.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2007.09.143</ArticleId><ArticleId IdType="pubmed">18164242</ArticleId></ArticleIdList></Reference><Reference><Citation>Grollemund V, et al. Machine learning in amyotrophic lateral sclerosis: Achievements, pitfalls, and future directions. Front. Neurosci. 2019;13:66. doi: 10.3389/fnins.2019.00135.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00135</ArticleId><ArticleId IdType="pmc">PMC6403867</ArticleId><ArticleId IdType="pubmed">30872992</ArticleId></ArticleIdList></Reference><Reference><Citation>Keizman D, et al. Low-grade systemic inflammation in patients with amyotrophic lateral sclerosis. Acta Neurol. Scand. 2009;119:383&#x2013;389. doi: 10.1111/j.1600-0404.2008.01112.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2008.01112.x</ArticleId><ArticleId IdType="pubmed">18976328</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadjar Y, et al. Elevated serum ferritin is associated with reduced survival in amyotrophic lateral sclerosis. PLoS ONE. 2012;7:e45034. doi: 10.1371/journal.pone.0045034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0045034</ArticleId><ArticleId IdType="pmc">PMC3443244</ArticleId><ArticleId IdType="pubmed">23024788</ArticleId></ArticleIdList></Reference><Reference><Citation>Poloni M, et al.  Circulating levels of tumour necrosis factor-<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>&#x3b1;</mml:mi></mml:math> and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci. Lett. 2000;287:211&#x2013;214. doi: 10.1016/S0304-3940(00)01177-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3940(00)01177-0</ArticleId><ArticleId IdType="pubmed">10863032</ArticleId></ArticleIdList></Reference><Reference><Citation>Berjaoui, S. et al. Complex inflammation MRNA-related response in ALS is region dependent. Neural Plast.2015, (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4537753</ArticleId><ArticleId IdType="pubmed">26301107</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS, et al. Regulatory t-lymphocytes mediate amyotrophic lateral sclerosis progression and survival. EMBO Mol. Med. 2013;5:64&#x2013;79. doi: 10.1002/emmm.201201544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201201544</ArticleId><ArticleId IdType="pmc">PMC3569654</ArticleId><ArticleId IdType="pubmed">23143995</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C-H, et al. Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 2016;3:e244. doi: 10.1212/NXI.0000000000000244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000244</ArticleId><ArticleId IdType="pmc">PMC4897985</ArticleId><ArticleId IdType="pubmed">27308305</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyon I, Weston J, Barnhill S, Vapnik V. Gene selection for cancer classification using support vector machines. Mach. Learn. 2002;46:389&#x2013;422. doi: 10.1023/A:1012487302797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1012487302797</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakotomamonjy A. Variable selection using SVM-based criteria. J. Mach. Learn. Res. 2003;3:1357&#x2013;1370.</Citation></Reference><Reference><Citation>Cedarbaum JM, et al. The alsfrs-r: A revised ALS functional rating scale that incorporates assessments of respiratory function. J. Neurol. Sci. 1999;169:13&#x2013;21. doi: 10.1016/S0022-510X(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan K, Zhang D. Feature selection and analysis on correlated gas sensor data with recursive feature elimination. Sens. Actuat. B Chem. 2015;212:353&#x2013;363. doi: 10.1016/j.snb.2015.02.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.snb.2015.02.025</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazli S, et al. Subject-independent mental state classification in single trials. Neural Netw. 2009;22:1305&#x2013;1312. doi: 10.1016/j.neunet.2009.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neunet.2009.06.003</ArticleId><ArticleId IdType="pubmed">19560898</ArticleId></ArticleIdList></Reference><Reference><Citation>Arlot S, Celisse A, et al. A survey of cross-validation procedures for model selection. Stat. Surv. 2010;4:40&#x2013;79. doi: 10.1214/09-SS054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1214/09-SS054</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu G, Huang JZ, et al. Asymptotic optimality and efficient computation of the leave-subject-out cross-validation. Ann. Stat. 2012;40:3003&#x2013;3030. doi: 10.1214/12-AOS1063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1214/12-AOS1063</ArticleId></ArticleIdList></Reference><Reference><Citation>Varoquaux G, et al. Assessing and tuning brain decoders: Cross-validation, caveats, and guidelines. NeuroImage. 2017;145:166&#x2013;179. doi: 10.1016/j.neuroimage.2016.10.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2016.10.038</ArticleId><ArticleId IdType="pubmed">27989847</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C-C, Lin C-J. LIBSVM: A library for support vector machines. ACM Trans. Intell. Syst. Technol. 2011;2:1&#x2013;27. doi: 10.1145/1961189.1961199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/1961189.1961199</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeys Y, Inza I, Larra&#xf1;aga P. A review of feature selection techniques in bioinformatics. Bioinformatics. 2007;23:2507&#x2013;2517. doi: 10.1093/bioinformatics/btm344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btm344</ArticleId><ArticleId IdType="pubmed">17720704</ArticleId></ArticleIdList></Reference><Reference><Citation>Bereman MS, Beri J, Enders JR, Nash T. Machine learning reveals protein signatures in CSF and plasma fluids of clinical value for ALS. Sci. Rep. 2018;8:16334. doi: 10.1038/s41598-018-34642-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-34642-x</ArticleId><ArticleId IdType="pmc">PMC6218542</ArticleId><ArticleId IdType="pubmed">30397248</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafson MP, et al. Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis. PLoS ONE. 2017;12:e0182002. doi: 10.1371/journal.pone.0182002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0182002</ArticleId><ArticleId IdType="pmc">PMC5526569</ArticleId><ArticleId IdType="pubmed">28742871</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandon&#xe0; A, Vasta R, Chi&#xf2; A, Di Camillo B. A dynamic Bayesian network model for the simulation of amyotrophic lateral sclerosis progression. BMC Bioinform. 2019;20:118. doi: 10.1186/s12859-019-2692-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-019-2692-x</ArticleId><ArticleId IdType="pmc">PMC6471677</ArticleId><ArticleId IdType="pubmed">30999865</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J, et al. Serum ferritin is a candidate biomarker of disease aggravation in amyotrophic lateral sclerosis. Biomed. Rep. 2018;9:333&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6142032</ArticleId><ArticleId IdType="pubmed">30233786</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima C, et al. Identification of erythrocyte biomarkers in amyotrophic lateral sclerosis. Clin. Hemorheol. Microcircul. 2016;63:423&#x2013;437. doi: 10.3233/CH-162066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-162066</ArticleId><ArticleId IdType="pubmed">27258202</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters S, et al.  The tgf-<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>&#x3b2;</mml:mi></mml:math> system as a potential pathogenic player in disease modulation of amyotrophic lateral sclerosis. Front. Neurol. 2017;8:669. doi: 10.3389/fneur.2017.00669.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00669</ArticleId><ArticleId IdType="pmc">PMC5736544</ArticleId><ArticleId IdType="pubmed">29326641</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobu&#x15b; A, Machali&#x144;ski B. Trophic factors in the therapeutic challenge against ALS: Current research directions. Update Amyotrophic Lateral Scler. 2016;213:67.</Citation></Reference><Reference><Citation>Spiller KJ, et al. Reduction of matrix metalloproteinase 9 (mmp-9) protects motor neurons from tdp-43-triggered death in rnls8 mice. Neurobiol. Dis. 2019;124:133&#x2013;140. doi: 10.1016/j.nbd.2018.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.11.013</ArticleId><ArticleId IdType="pmc">PMC7053168</ArticleId><ArticleId IdType="pubmed">30458231</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiou B, Connor J. Emerging and dynamic biomedical uses of ferritin. Pharmaceuticals. 2018;11:124. doi: 10.3390/ph11040124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph11040124</ArticleId><ArticleId IdType="pmc">PMC6316788</ArticleId><ArticleId IdType="pubmed">30428583</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez JDA. Lipid biomarkers for amyotrophic lateral sclerosis. Front. Neurol. 2019;10:284&#x2013;284. doi: 10.3389/fneur.2019.00284.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00284</ArticleId><ArticleId IdType="pmc">PMC6458258</ArticleId><ArticleId IdType="pubmed">31019485</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>